期刊
NATURE
卷 490, 期 7419, 页码 278-+出版社
NATURE PUBLISHING GROUP
DOI: 10.1038/nature11415
关键词
-
资金
- Action on Hearing Loss (RNID)
- Deafness Research UK
- Wellcome Trust [088719]
- Medical Research Council
- ESTOOLS
- Wellcome Trust VIP award
- RNID
- Medical Research Council [G0900919, G0801059, G0700785] Funding Source: researchfish
- RNID [G44, 515:SHE:MR] Funding Source: researchfish
- MRC [G0801059, G0700785, G0900919] Funding Source: UKRI
Deafness is a condition with a high prevalence worldwide, produced primarily by the loss of the sensory hair cells and their associated spiral ganglion neurons (SGNs). Of all the forms of deafness, auditory neuropathy is of particular concern. This condition, defined primarily by damage to the SGNs with relative preservation of the hair cells(1), is responsible for a substantial proportion of patients with hearing impairment(2). Although the loss of hair cells can be circumvented partially by a cochlear implant, no routine treatment is available for sensory neuron loss, as poor innervation limits the prospective performance of an implant(3). Using stem cells to recover the damaged sensory circuitry is a potential therapeutic strategy. Here we present a protocol to induce differentiation from human embryonic stem cells (hESCs) using signals involved in the initial specification of the otic placode. We obtained two types of otic progenitors able to differentiate in vitro into hair-cell-like cells and auditory neurons that display expected electrophysiological properties. Moreover, when transplanted into an auditory neuropathy model, otic neuroprogenitors engraft, differentiate and significantly improve auditory-evoked response thresholds. These results should stimulate further research into the development of a cell-based therapy for deafness.
作者
我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。
推荐
暂无数据